The immunomodulatory properties of mesenchymal stem cells (MSCs)

Since their discovery in 1991, mesenchymal stem cells, or MSCs, have been used as a promising method to build tissue. However, MSCs can do more for the development of cell and gene therapies. Find out more in our video.

With the latest research, our understanding of the mechanisms induced by MSCs in therapeutic applications has shifted:

MSCs also provide therapeutic benefits in the host body via paracrine effects and the stimulation of host cells, as they can modulate the innate and adaptive immune responses. Indeed, MSCs not only serve as tissue progenitor cells, but they also have the ability to alter the tissue environment.

How does this work to result in a therapeutic potential? Learn more in our video.


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video


Learn even more

Find out about the challenges and chances of MSCs in cancer therapy.

Read the article

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Luxembourg
    15. Monaco
    16. Netherlands
    17. Norway
    18. Poland
    19. Portugal
    20. Romania
    21. Slovakia
    22. Slovenia
    23. Spain
    24. Sweden
    25. Switzerland
    26. United Kingdom
  3. Asia
    1. India
    2. Israel
    3. Japan
    4. Malaysia
    5. Singapore
    6. South Korea
    7. Taiwan
    8. Thailand
Scroll to top